Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CyActiv Joint is an oral multi-ingredient dietary supplement developed by Cerule for joint comfort, mobility, and flexibility. It is a combination nutraceutical formulation containing a patented spirulina extract rich in phycocyanin, natural eggshell membrane, Boswellia serrata extract, and tart cherry extract. The product is positioned for joint discomfort and osteoarthritis-related symptoms, with a mechanism centered on anti-inflammatory and antioxidant activity, including modulation of cyclooxygenase-2 associated inflammatory signaling and provision of structural matrix components such as type I collagen, hyaluronic acid, and glycosaminoglycans that support cartilage, connective tissue, and musculoskeletal health. It is marketed as a dietary supplement rather than an FDA-approved pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CyActiv Joint.